{
    "nctId": "NCT06595758",
    "briefTitle": "This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR",
    "officialTitle": "Effects of Pharmacogenetics on Pharmacokinetics and Toxicity of Doxorubicin in Egyptian Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Doxorubicin plasma concentrations",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females aged \u2265 18 years\n* Performance status 0 or 1\n* No contraindication to chemotherapy\n* Adequate bone marrow\n* Adequate hepatic function\n* Adequate renal function\n\nExclusion Criteria:\n\n* Poorly controlled diabetes mellitus\n* Ischemic heart disease\n* Uncontrolled hypertension\n* Active infections\n* Baseline ejection fraction \\&amp;lt; 50%\n* Performance status \u2265 2\n* Pregnancy Lactation, bilateral breast cancer, male patients, primary surgery, distant metastases, other malignancies, inflammations, hematological disorders, autoimmune diseases, and patients taking non-steroidal anti-inflammatory drugs (NSAIDs), steroidal and antibiotic therapy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}